These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30608962)

  • 1. Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study.
    Wilton J; Liu J; Sullivan A; Rachlis B; Marchand-Austin A; Giles M; Light L; Rank C; Burchell AN; Gardner S; Sider D; Gilbert M; Kroch AE;
    PLoS One; 2019; 14(1):e0210096. PubMed ID: 30608962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohort profile: Development and profile of a population-based, retrospective cohort of diagnosed people living with HIV in Ontario, Canada (Ontario HIV Laboratory Cohort).
    Liu J; Wilton J; Sullivan A; Marchand-Austin A; Rachlis B; Giles M; Light L; Sider D; Kroch AE; Gilbert M;
    BMJ Open; 2019 May; 9(5):e027325. PubMed ID: 31133591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Nance RM; Delaney JAC; Simoni JM; Wilson IB; Mayer KH; Whitney BM; Aunon FM; Safren SA; Mugavero MJ; Mathews WC; Christopoulos KA; Eron JJ; Napravnik S; Moore RD; Rodriguez B; Lau B; Fredericksen RJ; Saag MS; Kitahata MM; Crane HM
    Ann Intern Med; 2018 Sep; 169(6):376-384. PubMed ID: 30140916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011.
    Burchell AN; Gardner S; Light L; Ellis BM; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; McGee F; Raboud J; Rachlis A; Wobeser W; Rourke SB
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e10-9. PubMed ID: 26322672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
    Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
    AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
    Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
    J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where Are They Now? Assessing if Persons Returned to HIV Care Following Loss to Follow-Up by Public Health Case Workers Were Engaged in Care in Follow-Up Years.
    Udeagu CN; Shah S; Misra K; Sepkowitz KA; Braunstein SL
    AIDS Patient Care STDS; 2018 May; 32(5):181-190. PubMed ID: 29750551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
    Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
    S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV Cohort.
    Blitz S; Antoniou T; Burchell A; Walmsley S; Light L; Gardner S; Rourke S; Cooper C; Kendall C; Loutfy M; Rachlis A; Wobeser W; Benoit A; Raboud J
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):303-310. PubMed ID: 28700406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
    Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
    J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina.
    Haider MR; Brown MJ; Harrison S; Yang X; Ingram L; Bhochhibhoya A; Hamilton A; Olatosi B; Li X
    AIDS Care; 2021 Mar; 33(3):290-298. PubMed ID: 31856584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
    Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
    J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
    Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
    BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
    PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.